Tabalumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Tabalumab, covering 2018-04-26 to 2019-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma [Phase 1]